Responses
Immune cell therapies and immune cell engineering
Short report
Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.